Regulatory News
Wednesday, March 30, 2016
BRIEF-Auris Medical completes enrollment of TACTT2 phase 3 trial of AM-101
* Completes Enrollment Of TACTT2 Phase 3 Trial Of AM-101 in
acute inner ear tinnitus
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment